These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28247948)

  • 21. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HePTP promotes migration and invasion in triple-negative breast cancer cells via activation of Wnt/β-catenin signaling.
    Yu L; Wang C; Pan F; Liu Y; Ren X; Zeng H; Shi Y
    Biomed Pharmacother; 2019 Oct; 118():109361. PubMed ID: 31545274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
    Peröbner I; Karow M; Jochum M; Neth P
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6.
    Zhang J; Yang Z; Li P; Bledsoe G; Chao L; Chao J
    Mol Cell Biochem; 2013 Jul; 379(1-2):295-301. PubMed ID: 23666756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-183 inhibits osteosarcoma cell growth and invasion by regulating LRP6-Wnt/β-catenin signaling pathway.
    Yang X; Wang L; Wang Q; Li L; Fu Y; Sun J
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1197-1203. PubMed ID: 29402412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways.
    Cruz-Lozano M; González-González A; Marchal JA; Muñoz-Muela E; Molina MP; Cara FE; Brown AM; García-Rivas G; Hernández-Brenes C; Lorente JA; Sanchez-Rovira P; Chang JC; Granados-Principal S
    Eur J Nutr; 2019 Dec; 58(8):3207-3219. PubMed ID: 30460610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Mutation of LRP6 Identified in Chinese Han Population Links Canonical WNT Signaling to Neural Tube Defects.
    Shi Z; Yang X; Li BB; Chen S; Yang L; Cheng L; Zhang T; Wang H; Zheng Y
    Birth Defects Res; 2018 Jan; 110(1):63-71. PubMed ID: 28960852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
    Yin L; Gao Y; Zhang X; Wang J; Ding D; Zhang Y; Zhang J; Chen H
    Oncotarget; 2016 Jul; 7(27):42126-42138. PubMed ID: 27363012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GRP78 activates the Wnt/HOXB9 pathway to promote invasion and metastasis of hepatocellular carcinoma by chaperoning LRP6.
    Xiong H; Xiao H; Luo C; Chen L; Liu X; Hu Z; Zou S; Guan J; Yang D; Wang K
    Exp Cell Res; 2019 Oct; 383(1):111493. PubMed ID: 31310747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
    Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
    J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.
    Bilir B; Kucuk O; Moreno CS
    J Transl Med; 2013 Nov; 11():280. PubMed ID: 24188694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.
    Gangrade A; Pathak V; Augelli-Szafran CE; Wei HX; Oliver P; Suto M; Buchsbaum DJ
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AQP5 promotes epithelial-mesenchymal transition and tumor growth through activating the Wnt/β-catenin pathway in triple-negative breast cancer.
    Zhu Z; Li T; Wang H; Jiao L
    Mutat Res; 2024 Jun; 829():111868. PubMed ID: 38959561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorogenic Acid Inhibits Epithelial-Mesenchymal Transition and Invasion of Breast Cancer by Down-Regulating LRP6.
    Xue W; Hao J; Zhang Q; Jin R; Luo Z; Yang X; Liu Y; Lu Q; Ouyang Y; Guo H
    J Pharmacol Exp Ther; 2023 Feb; 384(2):254-264. PubMed ID: 36456194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells.
    Lu W; Li Y
    J Cell Biochem; 2014 Oct; 115(10):1799-807. PubMed ID: 24905570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTK7 modulates Wnt signaling activity via LRP6.
    Bin-Nun N; Lichtig H; Malyarova A; Levy M; Elias S; Frank D
    Development; 2014 Jan; 141(2):410-21. PubMed ID: 24353057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung.
    Zhang J; Chen J; Wo D; Yan H; Liu P; Ma E; Li L; Zheng L; Chen D; Yu Z; Liang C; Peng J; Ren DN; Zhu W
    Clin Cancer Res; 2019 Aug; 25(15):4832-4845. PubMed ID: 31010839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P; Carlson JH; Wu H; Marcus A; Leyland-Jones B; Dey N
    Oncotarget; 2016 Jul; 7(28):43124-43149. PubMed ID: 27281609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.